
Elegen is blazing a path towards a biology-based economy with a highly innovative approach to DNA synthesis that delivers an industry leading length of 7kb in 7 business days with a 99.999% per base accuracy. Our multidisciplinary team of best-in-class biologists, chemists, hardware, and software engineers apply cutting-edge technologies and methods to solve critical bottlenecks in synthetic biology workflows to help our customers in pharma, biotech, agbio, and biomanufacturing streamline their work and realize the full potential of programmable biology.
This is an opportunity to join a rapidly growing company at an early stage and impact the development of its products, markets, processes, people, and culture.
We are seeking a highly motivated Staff Scientist to support our current automation platforms and drive process changes that will enable scaling out our DNA manufacturing process.
This is a rare and exciting opportunity for a lab automation scientist looking to take the next step in their career at a uniquely innovative, rapidly moving, high impact start-up. In addition to supporting our current automation platforms and bringing the next generation of lab manufacturing online you will help us establish a strong culture of mutual respect, integrity, and collaboration while working alongside some of Silicon Valley’s best scientists and engineers.
Essential Responsibilities:
Essential Candidate Profile:
Preferred Candidate Qualifications:
Salary and Benefits:
The annual base salary compensation for this role, if based in California is: $170,000 - $185,000. Compensation may be different in other locations. Final compensation also includes bonus, equity and benefits. Specific offer packages are determined by multiple factors, including candidate skill, experience, expertise, and location.
✓ Healthcare ✓ Dental ✓ Vision ✓ Learning Allowance
✓ 401K ✓ Flexible PTO ✓ Short Term Disability ✓ Fitness Allowance
✓ Long Term Disability ✓ Parental Leave Program ✓ Commuter Benefits
About The Company:
Founded and led by Dr. Matthew Hill and located in San Carlos, CA, Elegen is well-capitalized by top life science investors, including Andreessen Horowitz, 8VC, and KdT. The company is advised and staffed by leading biotechnology scientists and entrepreneurs, including Dr. Marc Unger, inventor of the Nanoflex™ valve, and former CSO of Fluidigm. Dr. Hill has a PhD from Stanford and a proven track record of advancing innovative technologies from invention to commercial success. Over eight years in his previous role as VP of R&D at a leading molecular diagnostics company, he co-invented and launched five precision molecular diagnostic products, including a best-in-class noninvasive prenatal test used by millions. These products earn more than $350 million per year in revenue and enabled an IPO.
Elegen is an Equal Opportunity Employer.
Elegen provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, genetic characteristics, or any other category protected by law. All applicants have rights under the following Federal Employment Laws:
805 - R&D
Menlo Park, CA
Partager sur :